NEW MEDRAD 3.0T PROSTATE ECOIL ENABLES PERSONALIZED TREATMENT PLANNING

Patients diagnosed with prostate cancer often undergo either a radical prostatectomy, complete removal of the prostate gland, or radiation treatment over large portions of the prostate to combat the cancer. The after-effects on the patient can include impotence, urinary incontinence, and bleeding. MEDRAD designed the 3.0T Prostate eCoil to produce very accurate diagnostic images of the prostate that may enable early diagnosis and staging of prostate cancer. The 3.0T Prostate eCoil can also be used to plan radiation therapy in a way that helps physicians localize treatment to only the affected part of the gland. By giving clinicians more accurate images for use in planning and delivering targeted treatment, the eCoil may help them personalize the patient's treatment.
PR Newswire